Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource

Reproductive Health

Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome

Fertil Steril.

Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, Epperson N, Teede H

doi: 10.1016/

Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype

Am J Obstet Gynecol.

Engmann L, Jin S, Sun F, Legro RS, Polotsky AJ, Hansen KR, Coutifaris C, Diamond MP, Eisenberg E, Zhang H, Santoro N; Reproductive Medicine Network

doi: 10.1016/j.ajog.2017.01.003.

Further Publications UrologyFurther Publications Gynecology

Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set

Hum Reprod.

Al Wattar BH, Teede H, Garad R, Franks S, Balen A, Bhide P, Piltonen T, Romualdi D, Laven J, Thondan M, Bueno-Cavanillas A, Moss N, Andrews C, Hawkes R, Mol BW, Khan KS, Thangaratinam S

doi: 10.1093/humrep/dez272.

Reproductive Health

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

BMC Med.

Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS

doi: 10.1186/s12916-020-01697-5.

Further Publications UrologyFurther Publications Gynecology

Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort

Hum Reprod.

Glintborg D, Jensen RC, Schmedes AV, Brandslund I, Kyhl HB, Nielsen TK, Andersen MS

doi: 10.1093/humrep/dez122.

Reproductive Health

Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)

Hum Reprod.

Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA

doi: 10.1093/humrep/deaa199.

Reproductive Health

The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome

Hum Reprod.

Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S

doi: 10.1093/humrep/dez214.

Reproductive Health

Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation

Hum Reprod.

Mostinckx L, Segers I, Belva F, Buyl R, Santos-Ribeiro S, Blockeel C, Smitz J, Anckaert E, Tournaye H, De Vos M

doi: 10.1093/humrep/dez086.

Reproductive Health

Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)

Hum Reprod

Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA

doi: 10.1093/humrep/deaa199

Related content

Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome

Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype

Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort

Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)

The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome

Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation

Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)